- M&A transactions in renewable energy:• Conducted extensive research and analysis on macroeconomic and market updates in the Americas to evaluate potential M&A transactions.• Performed industry-specific and valuation analysis for clients engaged in renewable energy sector, including power markets in SPP, PJM, MISO, and ERCOT to optimize trading decisions on wind, solar, and storage assets.• Compiled valuation models through NPV and DCF decision to support the team's business activities and client coverage, ensuring informed decision-making and strategic alignment with market opportunities.• Evaluated various resources, including renewable and battery storage options, and analyzed proposals such as third-party PPA contracts, acquisitions, and requests for proposals.- Bond Underwriting (ABS, Panda Bond):• Drafted marketing materials to present ABS issuer, aligning business profiles and capital structures with securitization opportunities, to attract both new and existing clients and expand the securitization business.• Conducted in-depth analysis of collateral attributes and simulate ABS transactions for the benefit of rating agencies, issuers, and investors using cash-flow modeling tools like IntexDealMaker, CAS, and VBA-based Excel models.• Devised ABS bond structures (tranche, enhancement, waterfall) to align with investor preferences, current market conditions, asset/liability yields, issuance levels and other market standard structural features.• Monitored market trends and ABS pricing to inform pricing strategies, minimize issuer clients' funding costs, and engaged actively in the book-building process to set the final offering price.• Offered policy explanation and business consultation to foreign issuers and investors according to their RMB-financing and investment demand.• Organized Panda Bond promotion roadshows and seminars targeting global issuers, investors and intermediaries in Americas.

Peptides, Circular RNA, RDC, Commercialization

- De SPAC transaction:• Worked in the CFO team to assist in USD$126m based trading execution of Nocturne Acquisition Corporation (MBTCU.OQ) at De-SPAC stage.• Collated Nasdaq listed SPAC deals cases about sponsors related transactions from SEC filings and EDGAR to support decision-making in merger transaction scheme.• Responsible for in-depth research of merger target companies, including biotechnology related sectors (brain and spinal cancers, and degenerative neurological conditions, and stroke) and crypto related sectors.• Conducted a quarter-periodicity financial projection and valuation for medical service asset using LBO.• Assigned in seeking for third-party service providers and academic experts from public commercial media and researched institutions globally for support in technical & commercial preliminary due diligence.